These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3694434

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhancement of oral bioavailability of spironolactone by beta- and gamma-cyclodextrin complexations.
    Seo H, Tsuruoka M, Hashimoto T, Fujinaga T, Otagiri M, Uekama K.
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):286-91. PubMed ID: 6850944
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities.
    Yoshida A, Yamamoto M, Irie T, Hirayama F, Uekama K.
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1059-63. PubMed ID: 2766408
    [Abstract] [Full Text] [Related]

  • 9. Effects of cyclodextrins on chlorpromazine-induced haemolysis and central nervous system responses.
    Uekama K, Irie T, Sunada M, Otagiri M, Iwasaki K, Okano Y, Miyata T, Kasé Y.
    J Pharm Pharmacol; 1981 Nov; 33(11):707-10. PubMed ID: 6118408
    [Abstract] [Full Text] [Related]

  • 10. Analysis of interfacial transfer and absorption behavior of drugs following dissolution from beta-cyclodextrin complexes.
    Uekama K, Uemura Y, Irie T, Otagiri M.
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3637-43. PubMed ID: 6671224
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improvement in percutaneous absorption of prednisolone by beta- and gamma-cyclodextrin complexations.
    Uekama K, Arimori K, Sakai A, Masaki K, Irie T, Otagiri M.
    Chem Pharm Bull (Tokyo); 1987 Jul; 35(7):2910-3. PubMed ID: 3677241
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protective mechanism of beta-cyclodextrin for the hemolysis induced with phenothiazine neuroleptics in vitro.
    Irie T, Sunada M, Otagiri M, Uekama K.
    J Pharmacobiodyn; 1983 Jun; 6(6):408-14. PubMed ID: 6138401
    [Abstract] [Full Text] [Related]

  • 16. Inactivation of sarin and soman by cyclodextrins in vitro.
    Désiré B, Saint-André S.
    Experientia; 1987 Apr 15; 43(4):395-7. PubMed ID: 3569488
    [Abstract] [Full Text] [Related]

  • 17. Different mode of prednisolone within alpha-, beta-, and gamma-cyclodextrins in aqueous solution and in solid state.
    Uekama K, Sakai A, Arimori K, Otagiri M, Saitô H.
    Pharm Acta Helv; 1985 Apr 15; 60(4):117-21. PubMed ID: 4011623
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interaction of tri-O-methyl-beta-cyclodextrin with drugs. II. Enhanced bioavailability of ketoprofen in rats when administered with tri-O-methyl-beta-cyclodextrin.
    Nakai Y, Yamamoto K, Terada K, Horibe H, Ozawa K.
    Chem Pharm Bull (Tokyo); 1983 Oct 15; 31(10):3745-7. PubMed ID: 6671012
    [No Abstract] [Full Text] [Related]

  • 20. [Enhanced bioavailability of acetohexamide by beta-cyclodextrin complexation (author's transl)].
    Uekama K, Matsuo N, Hirayama F, Ichibagase H, Arimori K, Tsubaki K, Satake K.
    Yakugaku Zasshi; 1980 Sep 15; 100(9):903-9. PubMed ID: 7218151
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.